Soterix Medical Wins CE Mark for Depression Therapy System

Soterix Medical has snapped up the CE Mark for its 1x1 tDCS therapy system for the treatment of major depressive disorder.

The noninvasive, nonsystemic therapeutic device delivers low-intensity direct current to a region of the cerebral cortex in the brain, which is responsible for controlling mood.

According to the New York, N.Y.-based company, the system does not have the side effects commonly associated with oral antidepressant medications. — Michael Cipriano